Home >Market Briefing >[KRX deadline | October 8] KOSPI retreats to ...

[KRX deadline | October 8] KOSPI retreats to the 6600 level... Foreign Investors and institutions net sold KRW 3.6 trillion

Subscribe for your daily dose of unconventional business news 🚀
Published: Oct 8, 2026

[KRX deadline | October 8] KOSPI retreats to the 6600 level... Foreign Investors and institutions net sold KRW 3.6 trillion

KOSPI falls for 3 consecutive trading days... Weak financial, automobile, and pharmaceutical stocks

KOSDAQ is also at 890 points... Stocks related to deferral of depreciation and ESS soar

On the 8th, the domestic stock market, KOSPI and KOSDAQ fell together. KOSPI fell for three consecutive trading days due to large-scale selling by foreign investors and institutions, falling to the 6,600 mark, and KOSDAQ also barely maintained the 890 mark amid weakness in bio stocks.

According to the Korea Exchange, KOSPI closed at 6,625.93, down 177.97 points (2.62%) from the previous trading day. KOSDAQ closed at 892.27, down 6.16 points (0.69%). The won-dollar exchange rate ended weekly trading at 1,338.5 won, down 1.9 won from the previous trading day.

KOSPI fell as investment sentiment across Asian stock markets weakened due to uncertainty over global government bond interest rates, and uncertainty over the Middle East situation became a burden despite the announcement of good performance by large semiconductor stocks. By industry, finance fell 4.1%, transportation equipment and parts fell 3.9%, pharmaceuticals fell 3.7%, and IT services fell 3.5%. Large-cap stocks fell 2.7%, mid-cap stocks fell 1.4%, and small-cap stocks fell 0.5%.

In terms of supply and demand, foreign investors net sold 1.9996 trillion won and institutions net sold 1.6632 trillion won, while individuals net bought 2.9051 trillion won. Foreign Investors net sold KRW 1.5066 trillion in electricity and electronics, and net sold KRW 289 billion and KRW 131.5 billion in finance and machinery and equipment, respectively.

KOSDAQ fell for two days in a row as differentiation by industry emerged amid volatility in international oil prices and government bond interest rates. By industry, pharmaceuticals fell 3.5%, general services fell 3.2%, and construction fell 2.9%. While institutions net sold 106.4 billion won, foreign investors and individuals net bought 64.7 billion won and 50.1 billion won, respectively.

Stocks related to the postponement of the delisting process soar... Expectations for redevelopment of the express terminal continue

Related stocks soared as the Korea Exchange decided to postpone the delisting process for failing to meet market capitalization standards. Hyungji I&C (011080) is 30.00%, Hyungji Global (308100) is 29.88%, Bioinfra (199730) is 29.93%, Preliminary Tech (250930) is 29.90%, Moa Data (288980) is 29.56%, Eugene Technology (240600) rose 30.00% and Newintech (012340) rose 29.95%.

Expectations for the redevelopment of the Seoul Express Bus Terminal and reassessment of the value of the shares held continued. Cheonil Express (000650) rose 22.57%, and Dongyang Express (084670) rose 29.91%, reaching the upper limit.

ESS-related stocks are strong… Stocks are excited about battery performance and new drug issues

LG Energy Solution (373220) rose 2.56% on the news that it recorded its highest quarterly sales. Samki Energy Solutions (419050) soared 29.93% as expectations for increased demand for energy storage system (ESS) components due to the spread of AI data centers were highlighted.

Dawon Nexview (323350) rose 17.46% on expectations of increased demand for high-end semiconductor substrates, and BGF Eco Materials (126600) rose 12.20% on the plan to tender and cancel treasury stocks worth 15 billion won. HLB Global (003580) rose 29.80% due to HLB Group's new drug development momentum.

On the other hand, Peptron (087010) plunged 29.94% on the news that the SmartDepot technology evaluation conducted with Eli Lilly was terminated without a follow-up commercialization contract. Hanmi Pharmaceutical (128940) fell 10.02% as profit-taking listings were put on sale despite the approval of a new obesity drug. Alteogen (196170) fell 6.23% on the news that a Dutch court ordered the suspension of sales of Keytruda SC in eight European countries in connection with a patent dispute.

Auto stocks also showed weakness. Hyundai Motor Company (005380) fell 3.42% due to the strong won and performance concerns, and Kia Motors (000270) fell 2.55% due to caution about the third quarter performance outlook.

NCSoft (036570) fell 6.53% as box office expectations for the new game ‘Aion 2’ decreased.

Follow us on social media